跳至主要内容
临床试验/NCT04629807
NCT04629807进行中(未招募)不适用

The Anterior Gen Plus Study

SeaSpine, Inc.2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2020年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
8
试验地点
2
主要终点
Assessment of fusion for the DBM versus CBM cohorts

研究概览

简要总结

A clinical study evaluating patients treated with the Demineralized Bone Matrix (DBM) as compared to a Cellular Bone Matrix (CBM) in anterior lumbar interbody fusion.

详细描述

A prospective, single-center, clinical study evaluating patients undergoing primary, contiguous 2-level ALIF without supplemental fixation treated with Demineralized Bone Matrix (DBM) as compared to a Cellular Bone Matrix (CBM).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥18 years of age
  • Requires anterior lumbar interbody (ALIF) fusion
  • Are physically and mentally able and willing to return for the scheduled follow up visits, follow post-operative instructions
  • Willing and able to sign study specific Informed Consent Form

排除标准

  • Signs of acute infection
  • Active malignancy and/or current chemotherapy
  • Prior fusion at operative or adjacent level
  • Institutionalized or a prisoner
  • Documented history of alcohol or drug abuse
  • Undergoing a worker's compensation case
  • Pregnancy
  • Participation in another research study involving another implant or drug that may affect the outcomes of this clinical study
  • Any other condition that the Investigator determines is unacceptable for enrollment into this clinical study

结局指标

主要结局

Assessment of fusion for the DBM versus CBM cohorts

时间窗: 12 months

Proportion of levels exhibiting fusion for the DBM cohort versus the CBM cohort

次要结局

  • Serious Adverse Events (SAEs)(24 Months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验